World.Health.Organization. WHO Coronavirus(COVID-19)Dashboard2021.Availablefrom:www.covid19.who.int/?gclid=EAIaIQobChMI5ZO7r9rD8gIVkkiRBR3JBgAoEAAYASABEgIDj_D_BwE.2.Berlin DA, Gulick RM, Martinez FJ. Severe covid-19.N Engl J Med. 2020;383(25):2451-60.3.Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al.Clinical features of patients infected with 2019 novelcoronavirus in Wuhan, China.Lancet.2020;395(10223):497-506.4.Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al.Clinical characteristics of 138 hospitalized patientswith 2019 novel coronavirus–infected pneumonia inWuhan, China. JAMA. 2020;323(11):1061-9.5.Puelles VG, Lütgehetmann M, Lindenmeyer MT,Sperhake JP, Wong MN, Allweiss L, et al. Multiorganand Renal Tropism of SARS-CoV-2. N Engl J Med.2020;383(6):590-2.6.Ziegler CG, Allon SJ, Nyquist SK, Mbano IM, MiaoVN, Tzouanas CN, et al. SARS-CoV-2 receptor ACE2is an interferon-stimulated gene in human airwayepithelial cells and is detected in specific cell subsets
across tissues. Cell. 2020;181(5):1016-35. e19.7.Saftig P, Klumperman J. Lysosome biogenesis andlysosomal membrane proteins: trafficking meetsfunction. Nat rev Mol cell biol. 2009;10(9):623-35.8.Ghosh S, Dellibovi-Ragheb TA, Kerviel A, Pak E, QiuQ, Fisher M, et al. β-Coronaviruses Use Lysosomesfor Egress Instead of the Biosynthetic SecretoryPathway. Cell. 2020;183(6):1520-35.e14.9.Snijder EJ, Limpens R. A unifying structural andfunctional model of the coronavirus replication
organelle: Tracking down RNA synthesis. PLoSBiol.2020;18(6):e3000715.10.Audano M, Schneider A, Mitro N.Mitochondria,
lysosomes, and dysfunction: their meaning inneurodegeneration. J Neurochem. 2018;147(3):291-309.11.Fleming SMSantiago NA, Mullin EJ, Pamphile S,Karkare S, Lemkuhl A, et al. The effect of manganeseexposure in Atp13a2-deficient mice.Neurotoxicology. 2018;64:256-66.12.Robinson M, Schor S, Barouch-Bentov R, Einav S.Viral journeys on theintracellular highways. Cell MolLife Sci. 2018;75(20):3693-714.13.Spataro R, Kousi M, Farhan SM, Willer JR, Ross JP,
Dion PA, et al. Mutations in ATP13A2 (PARK9) areassociated with an amyotrophic lateral sclerosis-likephenotype, implicating this locus in furtherphenotypic expansion. Hum genomics. 2019;13(1):1-10.14.Usenovic M, Tresse E, Mazzulli JR, Taylor JPKrainc D. Deficiency of ATP13A2 leads to lysosomaldysfunction, α-synuclein accumulation, andneurotoxicity. J Neurosci. 2012;32(12):4240-6.15.Matsui H, Sato F, Sato S, Koike M, Taruno Y, SaikiS, et al. ATP13A2 deficiency induces a decrease incathepsin D activity, fingerprint-like inclusion bodyformation, and selective degeneration ofdopaminergic neurons. FEBS Lett. 2013;587(9):1316-25.16.van Veen S, Martin S, Van den Haute C, Benoy V,Lyons J, Vanhoutte R, et al. ATP13A2 deficiencydisrupts lysosomal polyamine export. Nature.2020;578(7795):419-24.